This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Becton Dickinson and Company Limited. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: The Innovative Contributions of Aaron Jacob Tyznik
Introduction
Aaron Jacob Tyznik is a notable inventor based in San Jose, California. He has made significant contributions to the field of flow cytometry through his innovative patent. His work focuses on enhancing the capabilities of single-cell analysis, which is crucial for various biomedical applications.
Latest Patents
Aaron Jacob Tyznik holds a patent for "Bi-specific probes to enable the use of single-cell samples as single color compensation control." This patent discloses methods, compositions, and kits that are suitable for spectral unmixing and compensation in multi-parameter flow cytometry. The invention includes reagents that comprise two antibodies conjugated to one another to form a bispecific reagent. The first antibody has an affinity for a highly expressed antigen on the surface of a cell of interest, while the second antibody has an affinity for each of the antibody-dye conjugates in a multi-parameter panel. The patent also provides methods for using the bispecific reagent to determine spillover, perform compensation, and generate a compensation matrix.
Career Highlights
Aaron is currently employed at Becton Dickinson and Company Limited, where he continues to contribute to advancements in medical technology. His work is instrumental in improving the accuracy and efficiency of flow cytometry techniques, which are widely used in research and clinical settings.
Collaborations
Throughout his career, Aaron has collaborated with talented individuals such as James Ghadiali and Adam Wright. These collaborations have further enriched his work and contributed to the development of innovative solutions in the field.
Conclusion
Aaron Jacob Tyznik's contributions to the field of flow cytometry through his innovative patent demonstrate his commitment to advancing scientific research. His work not only enhances the capabilities of single-cell analysis but also paves the way for future innovations in biomedical applications.